NCT02251795View on ClinicalTrials.gov

Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

Tipranavir

DRUG

Ritonavir

DRUG

Darunavir

DRUG

Aspirin

single dose on day 2

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02251795 - Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects | Biotech Hunter | Biotech Hunter